دورية أكاديمية

A Single-Cell Atlas of Lymphocyte Adaptive Immune Repertoires and Transcriptomes Reveals Age-Related Differences in Convalescent COVID-19 Patients.

التفاصيل البيبلوغرافية
العنوان: A Single-Cell Atlas of Lymphocyte Adaptive Immune Repertoires and Transcriptomes Reveals Age-Related Differences in Convalescent COVID-19 Patients.
المؤلفون: Bieberich F; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Vazquez-Lombardi R; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Yermanos A; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.; Institute of Microbiology and Immunology, Department of Biology, ETH Zurich, Zurich, Switzerland.; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.; Botnar Research Centre for Child Health, Basel, Switzerland., Ehling RA; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Mason DM; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.; deepCDR Biologics AG, Basel, Switzerland., Wagner B; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Kapetanovic E; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Di Roberto RB; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Weber CR; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.; deepCDR Biologics AG, Basel, Switzerland., Savic M; Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland.; Department of Surgery, Oral and Cranio-Maxillofacial Surgery, University Hospital Basel, Basel, Switzerland.; Department of Health, Economics and Health Directorate, Canton Basel-Landschaft, Switzerland., Rudolf F; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Reddy ST; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.; Botnar Research Centre for Child Health, Basel, Switzerland.
المصدر: Frontiers in immunology [Front Immunol] 2021 Jul 12; Vol. 12, pp. 701085. Date of Electronic Publication: 2021 Jul 12 (Print Publication: 2021).
نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [Lausanne : Frontiers Research Foundation]
مواضيع طبية MeSH: Aging/*immunology , B-Lymphocytes/*immunology , CD4-Positive T-Lymphocytes/*immunology , CD8-Positive T-Lymphocytes/*immunology , COVID-19/*immunology , SARS-CoV-2/*physiology, Adaptive Immunity ; Adult ; Aged ; Cells, Cultured ; Convalescence ; Female ; Humans ; Male ; Middle Aged ; Receptors, Antigen, B-Cell/genetics ; Receptors, Antigen, T-Cell/genetics ; Single-Cell Analysis ; Transcriptome ; Young Adult
مستخلص: COVID-19 disease outcome is highly dependent on adaptive immunity from T and B lymphocytes, which play a critical role in the control, clearance and long-term protection against SARS-CoV-2. To date, there is limited knowledge on the composition of the T and B cell immune receptor repertoires [T cell receptors (TCRs) and B cell receptors (BCRs)] and transcriptomes in convalescent COVID-19 patients of different age groups. Here, we utilize single-cell sequencing (scSeq) of lymphocyte immune repertoires and transcriptomes to quantitatively profile the adaptive immune response in COVID-19 patients of varying age. We discovered highly expanded T and B cells in multiple patients, with the most expanded clonotypes coming from the effector CD8 + T cell population. Highly expanded CD8 + and CD4 + T cell clones show elevated markers of cytotoxicity (CD8: PRF1, GZMH, GNLY; CD4: GZMA), whereas clonally expanded B cells show markers of transition into the plasma cell state and activation across patients. By comparing young and old convalescent COVID-19 patients (mean ages = 31 and 66.8 years, respectively), we found that clonally expanded B cells in young patients were predominantly of the IgA isotype and their BCRs had incurred higher levels of somatic hypermutation than elderly patients. In conclusion, our scSeq analysis defines the adaptive immune repertoire and transcriptome in convalescent COVID-19 patients and shows important age-related differences implicated in immunity against SARS-CoV-2.
Competing Interests: Author DM and CW were employed by company deepCDR Biologics AG. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
(Copyright © 2021 Bieberich, Vazquez-Lombardi, Yermanos, Ehling, Mason, Wagner, Kapetanovic, Di Roberto, Weber, Savic, Rudolf and Reddy.)
References: Nat Methods. 2016 Apr;13(4):329-332. (PMID: 26950746)
Nat Methods. 2017 Sep;14(9):865-868. (PMID: 28759029)
Nature. 2020 Aug;584(7821):450-456. (PMID: 32698192)
Nat Methods. 2019 Dec;16(12):1289-1296. (PMID: 31740819)
Cell Rep. 2017 May 16;19(7):1467-1478. (PMID: 28514665)
Science. 2020 Aug 21;369(6506):956-963. (PMID: 32540903)
Nat Biotechnol. 2018 Dec 03;:. (PMID: 30531897)
MAbs. 2020 Jan-Dec;12(1):1729683. (PMID: 32097086)
J Exp Med. 2018 Oct 1;215(10):2520-2535. (PMID: 30154266)
Nature. 2020 Aug;584(7821):437-442. (PMID: 32555388)
Nat Med. 2020 Sep;26(9):1428-1434. (PMID: 32661393)
BMC Genomics. 2018 Jun 19;19(1):477. (PMID: 29914354)
Nat Med. 2018 May;24(5):604-609. (PMID: 29686423)
BMC Biotechnol. 2017 Jul 10;17(1):61. (PMID: 28693542)
Cell. 2015 May 21;161(5):1202-1214. (PMID: 26000488)
Cell. 2019 Dec 12;179(7):1636-1646.e15. (PMID: 31787378)
Immunity. 2020 Nov 17;53(5):1095-1107.e3. (PMID: 33128877)
J Immunol. 2010 Oct 1;185(7):3824-8. (PMID: 20802152)
Front Immunol. 2020 Sep 30;11:582010. (PMID: 33117392)
Front Immunol. 2020 Dec 15;11:605170. (PMID: 33384691)
Cell. 2020 Oct 1;183(1):158-168.e14. (PMID: 32979941)
Nat Med. 2020 Jun;26(6):842-844. (PMID: 32398875)
Oxf Open Immunol. 2020;1(1):iqaa003. (PMID: 34192266)
Trends Biotechnol. 2017 Mar;35(3):203-214. (PMID: 28341036)
Cell. 2020 Jun 25;181(7):1489-1501.e15. (PMID: 32473127)
J Immunol. 1988 Mar 1;140(5):1660-4. (PMID: 3126233)
Front Immunol. 2018 Jul 24;9:1618. (PMID: 30087674)
Front Immunol. 2014 Oct 20;5:520. (PMID: 25368619)
Trends Immunol. 2004 Jan;25(1):17-24. (PMID: 14698280)
Immunity. 2004 Jul;21(1):81-93. (PMID: 15345222)
Elife. 2018 Aug 28;7:. (PMID: 30152754)
J Immunol. 2006 Feb 15;176(4):2122-33. (PMID: 16455968)
Nat Rev Immunol. 2021 Apr;21(4):209-220. (PMID: 33024284)
Nat Biotechnol. 2020 Oct;38(10):1194-1202. (PMID: 32341563)
Nature. 2019 Feb;566(7744):398-402. (PMID: 30760926)
Nat Med. 2015 Jan;21(1):86-91. (PMID: 25501908)
BMC Med Genomics. 2008 Oct 23;1:53. (PMID: 18947405)
Life Sci Alliance. 2018 Aug 20;1(5):e201800060. (PMID: 30456377)
EBioMedicine. 2015 Nov 24;2(12):2070-9. (PMID: 26844287)
Nature. 2021 Mar;591(7851):639-644. (PMID: 33461210)
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13463-8. (PMID: 23898164)
Cell. 2020 Dec 10;183(6):1479-1495.e20. (PMID: 33171100)
Science. 2021 Feb 5;371(6529):. (PMID: 33408181)
Immun Ageing. 2010 Mar 16;7:4. (PMID: 20233447)
BMC Genomics. 2012 Aug 06;13:378. (PMID: 22866951)
Cell Immunol. 2007 May;247(1):36-48. (PMID: 17825804)
Nat Genet. 2017 May;49(5):659-665. (PMID: 28369038)
Cell. 2018 May 17;173(5):1307. (PMID: 29775597)
Nat Biotechnol. 2014 Apr;32(4):381-386. (PMID: 24658644)
Curr Opin Immunol. 1996 Feb;8(1):89-92. (PMID: 8729451)
Cell. 2017 Nov 16;171(5):1221-1223. (PMID: 29149608)
Curr Opin Immunol. 2017 Apr;45:97-102. (PMID: 28319733)
Cell. 2019 Jun 13;177(7):1888-1902.e21. (PMID: 31178118)
Nature. 2019 Feb;566(7744):393-397. (PMID: 30664748)
Nat Biotechnol. 2013 Feb;31(2):166-9. (PMID: 23334449)
Nat Med. 2020 Aug;26(8):1205-1211. (PMID: 32546824)
Sci Transl Med. 2015 Aug 19;7(301):301ra131. (PMID: 26290413)
Science. 2020 Aug 7;369(6504):643-650. (PMID: 32540902)
Nat Immunol. 2020 Nov;21(11):1336-1345. (PMID: 32887977)
Nat Biotechnol. 2010 Sep;28(9):965-9. (PMID: 20802495)
Immunity. 2020 Dec 15;53(6):1245-1257.e5. (PMID: 33326767)
Cell Rep Med. 2021 Feb 16;2(2):100204. (PMID: 33521695)
Sci Immunol. 2017 Mar 3;2(9):. (PMID: 28345074)
Mol Syst Biol. 2019 Jun 19;15(6):e8746. (PMID: 31217225)
Genome Biol. 2020 Jun 24;21(1):152. (PMID: 32580738)
Nat Biotechnol. 2015 Feb;33(2):210. (PMID: 25658286)
Cell Rep Med. 2021 Feb 16;2(2):100192. (PMID: 33495756)
Cell Discov. 2020 Oct 20;6:73. (PMID: 33101705)
Nat Rev Immunol. 2013 Apr;13(4):270-9. (PMID: 23524463)
Nat Immunol. 2020 Sep;21(9):1107-1118. (PMID: 32788748)
فهرسة مساهمة: Keywords: B cell; COVID-19; SARS-CoV-2; T cell; VDJ repertoire; antibody; single-cell
المشرفين على المادة: 0 (Receptors, Antigen, B-Cell)
0 (Receptors, Antigen, T-Cell)
تواريخ الأحداث: Date Created: 20210729 Date Completed: 20210817 Latest Revision: 20210817
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC8312723
DOI: 10.3389/fimmu.2021.701085
PMID: 34322127
قاعدة البيانات: MEDLINE
الوصف
تدمد:1664-3224
DOI:10.3389/fimmu.2021.701085